Visceral abdominal obesity – is there an increased prevalence in men presenting with testicular teratoma?

References

• Giovannucci E, Michaud D. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 2007;132:2208–25.
   PubMed Web of Science ®Google Scholar
• Borkan GA, Gerzof SG, Robbins AH, Hults DE, Silbert CK, Silbert JE. Assessment of abdominal fat content by computed tomography. Am J Clin Nutr 1982;36:172–7.
   PubMed Web of Science ®Google Scholar
• von Hafe P, Pina F, Pérez A, Tavares M, Barros H. Visceral fat accumulation as a risk factor for prostate cancer. Obes Res 2004;12:1930–5.
   PubMedGoogle Scholar
• Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000;21: 697–738.
   PubMed Web of Science ®Google Scholar
• Dixon AK. Abdominal fat assessed by computed tomography: sex difference in distribution. Clin Radiol 1983;34: 189–91.
   PubMed Web of Science ®Google Scholar
• Blouin K, Boivin A, Tchernof A. Androgens and body fat distribution. J Steroid Biochem Mol Biol 2008;108:272–80.
   PubMed Web of Science ®Google Scholar
• Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999;341:1097–105.
   PubMed Web of Science ®Google Scholar
• Kopelman PG. Obesity as a medical problem. Nature 2000; 404:635–43.
   PubMed Web of Science ®Google Scholar
• Willett WC, Manson JE, Stampfer MJ, Colditz GA, Rosner B, Speizer FE, . Weight, weight change, and coronary heart disease in women. Risk within the ‘normal’ weight range. JAMA 1995;273:461–5.
   PubMed Web of Science ®Google Scholar
• Schapira DV, Kumar NB, Lyman GH, Cavanagh D, Roberts WS, LaPolla J. Upper-body fat distribution and endometrial cancer risk. JAMA 1991;266:1808–11.
   PubMed Web of Science ®Google Scholar
• Swanson CA, Potischman N, Wilbanks GD, Twiggs LB, Mortel R, Berman ML, . Relation of endometrial cancer risk to past and contemporary body size and body fat distribution. Cancer Epidemiol Biomarkers Prev 1993;2:321–7.
   Google Scholar
• Schapira DV, Clark RA, Wolff PA, Jarrett AR, Kumar NB, Aziz NM. Visceral obesity and breast cancer risk. Cancer 1994;74:632–9.
   PubMed Web of Science ®Google Scholar
• MacInnis RJ, English DR, Hopper JL, Gertig DM, Haydon AM, Giles GG. Body size and composition and colon cancer risk in women. Int J Cancer 2006;118: 1496–500.
   Google Scholar
• Wolk A, Lindblad P, Adami HO. Nutrition and renal cell cancer. Cancer Causes Control 1996;7:5–18.
   PubMed Web of Science ®Google Scholar
• Farrow DC, Weiss NS, Lyon JL, Daling JR. Association of obesity and ovarian cancer in a case-control study. Am J Epidemiol 1989;129:1300–4.
   Google Scholar
• Chow WH, Blot WJ, Vaughan TL, Risch HA, Gammon MD, Stanford JL, . Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1998;90:150–5
   PubMed Web of Science ®Google Scholar
• Møller H, Mellemgaard A, Lindvig K, Olsen JH. Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 1994;30A:344–50.
   PubMed Web of Science ®Google Scholar
• Dieckmann KP, Hartmann JT, Classen J, Diederichs M, Pichlmeier U. Is increased body mass index associated with the incidence of testicular germ cell cancer? J Cancer Res Clin Oncol 2009;135:731–8.
   PubMed Web of Science ®Google Scholar
• Otake S, Takeda H, Suzuki Y, Fukui T, Watanabe S, Ishihama K, . Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance. Clin Cancer Res 2005;11:3642–6.
   PubMed Web of Science ®Google Scholar
• Skipworth RJ, Stewart GD, Dejong CH, Preston T, Fearon KC. Pathophysiology of cancer cachexia: much more than host-tumor interaction? Clin Nutr 2007;26: 667–76.
   Google Scholar
• Zamboni M, Armellini F, Turcato E, Todesco T, Bissoli L, Bergamo-Andreis IA, . Effect of weight loss on regional body fat distribution in premenopausal women. Am J Clin Nutr 1993;58:29–34.
   PubMed Web of Science ®Google Scholar
• Colles SL, Dixon JB, Marks P, Strauss BJ, O’Brien PE. Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging. Am J Clin Nutr 2006;84:304–11.
   PubMed Web of Science ®Google Scholar
• Doucet E, St-Pierre S, Alméras N, Imbeault P, Mauriège P, Pascot A, . Reduction of visceral adipose tissue during weight loss. Eur J Clin Nutr 2002;56:297–304.
   PubMedGoogle Scholar
• Ross R, Rissanen J. Mobilization of visceral and subcutaneous adipose tissue in response to energy restriction and exercise. Am J Clin Nutr 1994;60:695–703.
   PubMed Web of Science ®Google Scholar
• Weinsier RL, Hunter GR, Gower BA, Schutz Y, Darnell BE, Zuckerman PA. Body fat distribution in white and black women: different patterns of intraabdominal and subcutaneous abdominal adipose tissue utilization with weight loss. Am J Clin Nutr 2001;74:631–6.
   PubMed Web of Science ®Google Scholar
• Janssen I, Ross R. Effects of sex on the change in visceral, subcutaneous adipose tissue and skeletal muscle in response to weight loss. Int J Obes Relat Metab Disord 1999;23:1035–46.
   PubMed Web of Science ®Google Scholar
• Björntorp P. The regulation of adipose tissue distribution in humans. Int J Obes Relat Metab Disord 1996;20: 291–302.
   PubMed Web of Science ®Google Scholar
• Harish K, Dharmalingam M, Himanshu M. Study protocol: insulin and its role in cancer. BMC Endocr Disord 2007;22:7–10.
   Google Scholar
• Feng Y, Dimitrov DS. Monoclonal antibodies against components of the IGF system for cancer treatment. Curr Opin Drug Discov Devel 2007;11:178–85.
   Google Scholar
• Durand MK, Bødker JS, Christensen A, Dupont DM, Hansen M, Jensen JK, . Plasminogen activator inhibitor-I and tumor growth, invasion, and metastasis. Thromb Haemost 2004;91:438–49.
   PubMed Web of Science ®Google Scholar
• Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998;83:847–50.
   PubMed Web of Science ®Google Scholar
• Heikkilä K, Ebrahim S, Lawlor DA. Systematic review of the association between circulating interleukin-6 (IL-6) and cancer. Eur J Cancer 2008;44:937–45.
   PubMed Web of Science ®Google Scholar
• Schafer ZT, Brugge JS. IL-6 involvement in epithelial cancers. J Clin Invest 2007;117:3660–3.
   PubMed Web of Science ®Google Scholar
• Walsh PC. The endocrinology of testicular tumors. Recent Results Cancer Res 1977;60:196–201.
   Google Scholar
• Daniels IR, Layer GT. Testicular tumors presenting as gynaecomastia. Eur J Surg Oncol 2003;29:437–9.
   Google Scholar
• Uysal Z, Bakkaloğlu M. Serum estradiol as a tumor marker for non-seminomatous germinal cell tumors (NSGCT) of the testis. Int Urol Nephrol 1987;19:415–18.
   Google Scholar
• Yoshida S, Inadera H, Ishikawa Y, Shinomiya M, Shirai K, Saito Y. Endocrine disorders and body fat distribution. Int J Obes 1991;15(Suppl 2):37–40.
   Google Scholar
• Huddart RA, Norman A, Shahidi M, Horwich A, Coward D, Nicholls J, . Cardiovascular disease as a long term complication of treatment for testicular cancer. J Clin Oncol 2003;21:1513–23.
   PubMed Web of Science ®Google Scholar
• Gietema JA, Sleijfer DT, Willemse PH, Koops H, van Ittersum E, Verschuren WM, . Long term follow up of cardiovascular risk factors in patients given chemotherapy for disseminated nonseminomatous testicular cancer. Ann Intern Med 1992;116:709–15.
   PubMed Web of Science ®Google Scholar
• Sjostrom L, Lonn L, Chowdhury B, Grangard Lissner L, Sjostrom D, Sullivan L. The sagittal diameter is a valid marker of the visceral adipose tissue volume. Angel A, Anderson H, Bouchard C, Lau D, Leiter L, Mendelson R. Progress in obesity research. Proceedings of the Seventh International Congress on Obesity, vol 7. Toronto, Canada, August 20–25, 1994. London: John Libbey & Company; 1996. 309–19.
   Google Scholar